The pleiotropic effects of vitamin D in gynaecological and obstetric diseases: An overview on a hot topic

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Colonese, Francesca ^a   Laganà, Antonio Simone ^b   Colonese, Elisabetta ^c   Sofo, Vincenza ^b   Salmeri, Francesca Maria ^b   Granese, Roberta ^b   Triolo, Onofrio ^b  

^a Department of Oncology San Rafaele Scientific Institute ^*  (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c Melloni Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D; CALCITRIOL RECEPTOR; VDR PROTEIN, HUMAN;

BREAST CANCER; CARCINOGENESIS; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GYNECOLOGIC DISEASE; HUMAN; INSULIN RESISTANCE; META ANALYSIS (TOPIC); OVARY CANCER; OVARY POLYCYSTIC DISEASE; PATIENT RISK; PLEIOTROPY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW (TOPIC); VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; VITAMIN METABOLISM; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY; VITAMIN D DEFICIENCY;

DIABETES, GESTATIONAL; ENDOMETRIOSIS; FEMALE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; POLYCYSTIC OVARY SYNDROME; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84929377534     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/986281     Document Type: Review

References (138)

1. S. Lucisano, M. Buemi, A. Passantino, C. Aloisi, V. Cernaro, and D. Santoro, "New insights on the role of vitamin D in the progression of renal damage", Kidney and Blood Pressure Research, vol. 37, no. 6, pp. 667-678, 2013.
2. V. Savica, G. Bellinghieri, P. Monardo, U. Muraca, and D. Santoro, "An update on calcium metabolism alterations and cardiovascular risk in patients with chronic kidney disease: questions, myths and factss", Journal of Nephrology, vol. 26, no. 3, pp. 456-464, 2013.
3. M. F. Holick and T. C. Chen, "Vitamin D deficiency: a worldwide problem with health consequences", The American Journal of Clinical Nutrition, vol. 87, no. 4, pp. 1080S-1086S, 2008.
4. H. L. Henry, "Vitamin D hydroxylases", Journal of Cellular Biochemistry, vol. 49, no. 1, pp. 4-9, 1992.
5. D. W. Nebert and F. J. Gonzalez, "P450 genes: structure, evolution, and regulation", Annual Review of Biochemistry, vol. 56, pp. 945-993, 1987.
6. B. Lehmann, K. Querings, and J. Reichrath, "Vitamin D and skin: new aspects for dermatology", Experimental Dermatology, vol. 13, supplement 4, pp. 11-15, 2004.
7. V. Tangpricha, J. N. Flanagan, L. W. Whitlatch et al., "25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue", The Lancet, vol. 357, no. 9269, pp. 1673-1674, 2001.
8. S. Pillai, D. D. Bikle, and P. M. Elias, "1, 25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation", The Journal of Biological Chemistry, vol. 263, no. 11, pp. 5390-5395, 1988.
9. D. Santoro, D. Caccamo, G. Gagliostro et al., "Vitamin D metabolism and activity as well as genetic variants of the vitamin D receptor (VDR) in chronic kidney disease patients", Journal of Nephrology, vol. 26, no. 4, pp. 636-644, 2013.
10. A. R. Baker, D. P. McDonnell, M. Hughes et al., "Cloning and expression of full-length cDNA encoding human vitamin D receptor", Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 10, pp. 3294-3298, 1988.
11. W. E. Stumpf, M. Sar, F. A. Reid, Y. Tanaka, and H. F. DeLuca, "Target cells for 1, 25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid", Science, vol. 206, no. 4423, pp. 1188-1190, 1979.
12. S. Y. Kim, "The pleiomorphic actions of vitamin D and its importance for children", Annals of Pediatric Endocrinology & Metabolism, vol. 18, no. 2, pp. 45-54, 2013.
13. M. R. Haussler, D. J. Mangelsdorf, B. S. Komm et al., "Molecular biology of the vitamin D hormone", Recent Progress in Hormone Research, vol. 44, pp. 263-305, 1988.
14. S. A. Kliewer, K. Umesono, D. J. Mangelsdorf, and R. M. Evans, "Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling", Nature, vol. 355, no. 6359, pp. 446-449, 1992.
15. M. Labuda, T. M. Fujiwara, M. V. Ross et al., "Two hereditary deffects related to vitamin D metabolism map to the same region of human chromosome 12q13-14", Journal of Bone and Mineral Research, vol. 7, no. 12, pp. 1447-1453, 1992.
16. V. C. Yu, C. Delsert, B. Andersen et al., "RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements", Cell, vol. 67, no. 6, pp. 1251-1266, 1991.
17. M. Leid, P. Kastner, R. Lyons et al., "Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently", Cell, vol. 68, no. 2, pp. 377-395, 1992.
18. A. Pizzo, A. S. Laganà, and L. Barbaro, "Comparison between effects of myo-inositol and d-chiro-inositol on ovarian function and metabolic factors in women with PCOS", Gynecological Endocrinology, vol. 30, no. 3, pp. 205-208, 2014.
19. M. Asuncioń, R. M. Calvo, J. L. San MilláN, J. Sancho, S. Avila, and H. F. Escobar-Morreale, "A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain", Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 7, pp. 2434-2438, 2000.
20. E. Diamanti-Kandarakis, C. R. Kouli, A. T. Bergiele et al., "A survey of the polycystic ovary syndrome in the Greek Island of Lesbos: hormonal and metabolic profle", Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 11, pp. 4006-4011, 1999.
21. A. Dunaif, "Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis", Endocrine Reviews, vol. 18, no. 6, pp. 774-800, 1997.
22. E. Wehr, R. Möller, R. Horejsi et al., "Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome", Wiener Klinische Wochenschrif, vol. 121, no. 7-8, pp. 262-269, 2009.
23. D. A. Ehrmann, "Polycystic ovary syndrome", The New England Journal of Medicine, vol. 352, no. 12, pp. 1223-1277, 2005.
24. S. Hahn, U. Haselhorst, S. Tan et al., "Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome", Experimental and Clinical Endocrinology and Diabetes, vol. 114, no. 10, pp. 577-583, 2006.
25. H. W. R. Li, R. E. Brereton, R. A. Anderson, A. M. Wallace, and C. K. M. Ho, "Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome", Metabolism: Clinical and Experimental, vol. 60, no. 10, pp. 1475-1481, 2011.
26. E. Wehr, T. R. Pieber, and B. Obermayer-Pietsch, "Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study", Journal of Endocrinological Investigation, vol. 34, no. 10, pp. 757-763, 2011.
27. R. Yildizhan, M. Kurdoglu, E. Adali et al., "Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome", Archives of Gynecology and Obstetrics, vol. 280, no. 4, pp. 559-563, 2009.
28. E. Wehr, S. Pilz, N. Schweighofer et al., "Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome", European Journal of Endocrinology, vol. 161, no. 4, pp. 575-582, 2009.
29. E. Wehr, O. Trummer, A. Giuliani, H.-J. Gruber, T. R. Pieber, and B. Obermayer-Pietsch, "Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D defciency in polycystic ovary syndrome", European Journal of Endocrinology, vol. 164, no. 5, pp. 741-749, 2011.
30. H. Darwish and H. F. DeLuca, "Vitamin D-regulated gene expression", Critical Reviews in Eukaryotic Gene Expression, vol. 3, no. 2, pp. 89-116, 1993.
31. C. Potera, "Diet and nutrition: vitamin D regulates MS gene", Environmental Health Perspectives, vol. 117, no. 5, p. A196, 2009.
32. T. Mahmoudi, "Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk", Fertility and Sterility, vol. 92, no. 4, pp. 1381-1383, 2009.
33. A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-Hughes, "The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis", The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 6, pp. 2017-2029, 2007.
34. B. Maestro, N. Dávila, M. C. Carranza, and C. Calle, "Identifcation of a vitamin D response element in the human insulin receptor gene promoter", Journal of Steroid Biochemistry and Molecular Biology, vol. 84, no. 2-3, pp. 223-230, 2003.
35. B. Maestro, S. Molero, S. Bajo, N. Dávila, and C. Calle, "Transcriptional activation of the human insulin receptor gene by 1, 25-dihydroxyvitamin D3", Cell Biochemistry and Function, vol. 20, no. 3, pp. 227-232, 2002.
36. R. D. G. Milner and C. N. Hales, "The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro", Diabetologia, vol. 3, no. 1, pp. 47-49, 1967.
37. D. Bikle, "Nonclassic actions of vitamin D", Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 1, pp. 26-34, 2009.
38. S. E. Shoelson, L. Herrero, and A. Naaz, "Obesity, infammation, and insulin resistance", Gastroenterology, vol. 132, no. 6, pp. 2169-2180, 2007.
39. Y. H. M. Krul-Poel, C. Snackey, Y. Louwers et al., "The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review", European Journal of Endocrinology, vol. 169, no. 6, pp. 853-865, 2013.
40. H. R. Ardabili, B. P. Gargari, and L. Farzadi, "Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency", Nutrition Research, vol. 32, no. 3, pp. 195-201, 2012.
41. B. E. Metzger and D. R. Coustan, "Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. The Organizing Committee", Diabetes Care, vol. 21, supplement 2, pp. B161-B167, 1998.
42. P. M. Catalano, E. D. Tyzbir, R. R. Wolfe et al., "Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes", American Journal of Physiology: Endocrinology and Metabolism, vol. 264, no. 1, pp. E60-E67, 1993.
43. P. M. Catalano, L. Huston, S. B. Amini, and S. C. Kalhan, "Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus", The American Journal of Obstetrics and Gynecology, vol. 180, no. 4, pp. 903-916, 1999.
44. F. Corrado, R. D'Anna, A. S. Laganà, and A. Di Benedetto, "Abnormal glucose tolerance later in life in women afected by glucose intolerance during pregnancy", Journal of Obstetrics & Gynaecology, vol. 34, no. 2, pp. 123-126, 2014.
45. L. G. Danescu, S. Levy, and J. Levy, "Vitamin D and diabetes mellitus", Endocrine, vol. 35, no. 1, pp. 11-17, 2009.
46. J. P. Reis, D. von Mühlen, D. Kritz-Silverstein, D. L. Wingard, and E. Barrett-Connor, "Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in communitydwelling older adults", Diabetes Care, vol. 30, no. 6, pp. 1549-1555, 2007.
47. P. S. Y. Cheung, N. W. Thompson, T. E. Brothers, and A. I. Vinik, "Effect of hyperparathyroidism on the control of diabetes mellitus", Surgery, vol. 100, no. 6, pp. 1039-1047, 1986.
48. W. H. Taylor, "The prevalence of diabetes mellitus in patients with primary hyperparathyroidism and among their relatives", Diabetic Medicine, vol. 8, no. 7, pp. 683-687, 1991.
49. Z. Maghbooli, A. Hossein-Nezhad, F. Karimi, A.-R. Shafaei, and B. Larijani, "Correlation between vitamin D3 deficiency and insulin resistance in pregnancy", Diabetes/Metabolism Research and Reviews, vol. 24, no. 1, pp. 27-32, 2008.
50. C. Zhang, C. Qiu, F. B. Hu et al., "Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus", PLoS ONE, vol. 3, no. 11, Article ID e3753, 2008.
51. S. S. Zuhur, R. S. Erol, I. Kuzu, and Y. Altuntas, "The relationship between low maternal serum 25-hydroxyvitamin D levels and gestational diabetes mellitus according to the severity of 25-hydroxyvitamin D deficiency", Clinics, vol. 68, no. 5, pp. 658-664, 2013.
52. M. Makgoba, S. M. Nelson, M. Savvidou, C.-M. Messow, K. Nicolaides, and N. Sattar, "First-trimester circulating 25-hydroxyvitamin D levels and development of gestational diabetes mellitus", Diabetes Care, vol. 34, no. 5, pp. 1091-1093, 2011.
53. J. M. Roberts, "Preeclampsia: what we know and what we do not know", Seminars in Perinatology, vol. 24, no. 1, pp. 24-28, 2000.
54. J. H. Lee, J. H. O'Keefe, D. Bell, D. D. Hensrud, and M. F. Holick, "Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?" Journal of the American College of Cardiology, vol. 52, no. 24, pp. 1949-1956, 2008.
55. M. F. Holick, "Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis", The American Journal of Clinical Nutrition, vol. 79, no. 3, pp. 362-371, 2004.
56. Y. C. Li, G. Qiao, M. Uskokovic, W. Xiang, W. Zheng, and J. Kong, "Vitamin D: a negative endocrine regulator of the reninangiotensin system and blood pressure", Journal of Steroid Biochemistry and Molecular Biology, vol. 89-90, no. 1-5, pp. 387-392, 2004.
57. A. Cardús, E. Parisi, C. Gallego, M. Aldea, E. Fernández, and J. M. Valdivielso, "1, 25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway", Kidney International, vol. 69, no. 8, pp. 1377-1384, 2006.
58. P. August, B. Marcaccio, J. M. Gertner, M. L. Druzin, L. M. Resnick, and J. H. Laragh, "Abnormal 1, 25-dihydroxyvitamin D metabolism in preeclampsia", American Journal of Obstetrics & Gynecology, vol. 166, no. 4, pp. 1295-1299, 1992.
59. E. Hyppönen, A. Cavadino, D. Williams et al., "Vitamin D and Pre-Eclampsia: original data, systematic review and metaanalysis", Annals of Nutrition & Metabolism, vol. 63, no. 4, pp. 331-340, 2013.
60. M. Haugen, A. L. Brantsaeter, L. Trogstad et al., "Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women", Epidemiology, vol. 20, no. 5, pp. 720-726, 2009.
61. M. Tabesh, A. Salehi-Abargouei, M. Tabesh, and A. Esmaillzadeh, "Maternal vitamin D status and risk of pre-eclampsia: a systematic review and meta-analysis", Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 8, pp. 3165-3173, 2013.
62. P. M. Brannon, "Vitamin D and adverse pregnancy outcomes: beyond bone health and growth", Proceedings of the Nutrition Society, vol. 71, no. 2, pp. 205-212, 2012.
63. M. C. Yoder, L. E. Mead, D. Prater et al., "Redefning endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals", Blood, vol. 109, no. 5, pp. 1801-1809, 2007.
64. E. Ainy, A. A. M. Ghazi, and F. Azizi, "Changes in calcium, 25 (OH) vitamin D3 and other biochemical factors during pregnancy", Journal of Endocrinological Investigation, vol. 29, no. 4, pp. 303-307, 2006.
65. L. M. Bodnar, J. M. Catov, H. N. Simhan, M. F. Holick, R. W. Powers, and J. M. Roberts, "Maternal vitamin D defciency increases the risk of preeclampsia", Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 9, pp. 3517-3522, 2007.
66. A. Halhali, L. Díaz, D. Barrera, E. Avila, and F. Larrea, "Placental calcitriol synthesis and IGF-I levels in normal and preeclamptic pregnancies", The Journal of Steroid Biochemistry and Molecular Biology, vol. 144, part A, pp. 44-49, 2014.
67. Y. Weisman, A. Harell, S. Edelstein, M. David, Z. Spirer, and A. Golander, "1α, 25-Dihydroxyvitamin D3 and 24, 25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta", Nature, vol. 281, no. 5729, pp. 317-319, 1979.
68. L. Díaz, I. Sánchez, E. Avila, A. Halhali, F. Vilchis, and F. Larrea, "Identification of a 25-hydroxyvitamin D3 1?-hydroxylase gene transcription product in cultures of human syncytiotrophoblast cells", The Journal of Clinical Endocrinology & Metabolism, vol. 85, no. 7, pp. 2543-2549, 2000.
69. K. Pospechova, V. Rozehnal, L. Stejskalova et al., "Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines", Molecular and Cellular Endocrinology, vol. 299, no. 2, pp. 178-187, 2009.
70. D. Zehnder, K. N. Evans, M. D. Kilby et al., "The ontogeny of 25-hydroxyvitamin D3 1α-hydroxylase expression in human placenta and decidua", The American Journal of Pathology, vol. 161, no. 1, pp. 105-114, 2002.
71. A. M. Baker, S. Haeri, C. A. Camargo Jr., J. A. Espinola, and A. M. Stuebe, "A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia", Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 11, pp. 5105-5109, 2010.
72. C. J. Robinson, M. C. Alanis, C. L. Wagner, B. W. Hollis, and D. D. Johnson, "Plasma 25-hydroxyvitamin D levels in earlyonset severe preeclampsia", American Journal of Obstetrics and Gynecology, vol. 203, no. 4, pp. 366.e1-366.e6, 2010.
73. J. M. Roberts and C. A. Hubel, "The two stage model of preeclampsia: variations on the theme", Placenta, vol. 30, supplement, pp. S32-S37, 2009.
74. S. Q. Wei, F. Audibert, N. Hidiroglou et al., "Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia", BJOG, vol. 119, no. 7, pp. 832-839, 2012.
75. K. N. Evans, J. N. Bulmer, M. D. Kilby, and M. Hewison, "Vitamin D and placental-decidual function", Journal of the Society for Gynecologic Investigation, vol. 11, no. 5, pp. 263-271, 2004.
76. A. H. Zarnani, M. Shahbazi, A. Salek-Moghaddam et al., "Vitamin D3 receptor is expressed in the endometrium of cycling mice throughout the estrous cycle", Fertility and Sterility, vol. 93, no. 8, pp. 2738-2743, 2010.
77. T. Yoshizawa, Y. Handa, Y. Uematsu et al., "Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning", Nature Genetics, vol. 16, no. 4, pp. 391-396, 1997.
78. P. Viganò, D. Lattuada, S. Mangioni et al., "Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system", Journal of Molecular Endocrinology, vol. 36, no. 3, pp. 415-424, 2006.
79. B. Rudick, S. Ingles, K. Chung, F. Stanczyk, R. Paulson, and K. Bendikson, "Characterizing the influence of vitamin D levels on IVF outcomes", Human Reproduction, vol. 27, no. 11, pp. 3321-3327, 2012.
80. F. Aghajafari, T. Nagulesapillai, P. E. Ronksley, S. C. Tough, M. O'Beirne, and D. M. Rabi, "Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies", BMJ, vol. 346, no. 7902, Article ID f1169, 2013.
81. S. Ozkan, S. Jindal, K. Greenseid et al., "Replete vitamin D stores predict reproductive success following in vitro fertilization", Fertility and Sterility, vol. 94, no. 4, pp. 1314-1319, 2010.
82. A. Aleyasin, M. A. Hosseini, A. Mahdavi et al., "Predictive value of the level of vitamin D in follicular fluid on the outcome of assisted reproductive technology", European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 159, no. 1, pp. 132-137, 2011.
83. G. M. Anifandis, K. Dafopoulos, C. I. Messini et al., "Prognostic value of follicular fuid 25-OH vitamin D and glucose levels in the IVF outcome", Reproductive Biology and Endocrinology, vol. 8, article 91, 2010.
84. N. P. Polyzos, E. Anckaert, L. Guzman et al., "Vitamin D deficiency and pregnancy rates in women undergoing single embryo, blastocyst stage, transfer (SET) for IVF/ICSI", Human Reproduction, vol. 29, no. 9, pp. 2032-2040, 2014.
85. G. A. J. Dunselman, N. Vermeulen, C. Becker et al., "ESHRE guideline: management of women with endometriosis", Human Reproduction, vol. 29, no. 3, pp. 400-412, 2014.
86. O. Triolo, A. S. Laganà, and E. Sturlese, "Chronic pelvic pain in endometriosis: an overview", Journal of Clinical Medicine Research, vol. 5, no. 3, pp. 153-163, 2013.
87. S. Butticè, A. S. Laganà, V. Barresi et al., "Lumbar ureteral stenosis due to endometriosis: our experience and review of the literature", Case Reports in Urology, vol. 2013, Article ID 812475, 5 pages, 2013.
88. A. S. Laganà, E. Sturlese, G. Retto, V. Sofo, and O. Triolo, "Interplay between misplaced Müllerian-derived stem cells and peritoneal immune dysregulation in the pathogenesis of endometriosis", Obstetrics and Gynecology International, vol. 2013, Article ID 527041, 20 pages, 2013.
89. F. M. Salmeri, A. S. Laganà, V. Sofo et al., "Behavior of tumor necrosis factor-α and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages", Reproductive Sciences, vol. 22, no. 2, pp. 165-172, 2015.
90. A. Agic, H. Xu, C. Altgassen et al., "Relative expression of 1, 25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers", Reproductive Sciences, vol. 14, no. 5, pp. 486-497, 2007.
91. L. Vuolo, C. di Somma, A. Faggiano, and A. Colao, "Vitamin D and cancer", Frontiers in Endocrinology, vol. 3, article 58, 2012.
92. D. D'Ambrosio, M. Cippitelli, M. G. Cocciolo et al., "Inhibition of IL-12 production by 1, 25-dihydroxyvitamin D3. Involvement of NF-αB downregulation in transcriptional repression of the p40 gene", Journal of Clinical Investigation, vol. 101, no. 1, pp. 252-262, 1998.
93. E. Sturlese, F. M. Salmeri, G. Retto et al., "Dysregulation of the Fas/FasL system in mononuclear cells recovered from peritoneal fuid of women with endometriosis", Journal of Reproductive Immunology, vol. 92, no. 1-2, pp. 74-81, 2011.
94. F. Baeke, E. Van Etten, L. Overbergh, and C. Mathieu, "Vitamin D3 and the immune system: maintaining the balance in health and disease", Nutrition Research Reviews, vol. 20, no. 1, pp. 106-118, 2007.
95. C. Mathieu and L. Adorini, "The coming of age of 1, 25-dihydroxyvitamin D3 analogs as immunomodulatory agents", Trends in Molecular Medicine, vol. 8, no. 4, pp. 174-179, 2002.
96. E. van Etten, K. Stofels, C. Gysemans, C. Mathieu, and L. Overbergh, "Regulation of vitamin D homeostasis: implications for the immune system", Nutrition Reviews, vol. 66, no. 10, supplement 2, pp. S125-S134, 2008.
97. L. Sayegh, G. E. H. Fuleihan, and A. H. Nassar, "Vitamin D in endometriosis: a causative or confounding factor?" Metabolism, vol. 63, no. 1, pp. 32-41, 2014.
98. H. R. Harris, J. E. Chavarro, S. Malspeis, W. C. Willett, and S. A. Missmer, "Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study", The American Journal of Epidemiology, vol. 177, no. 5, pp. 420-430, 2013.
99. J. Borkowski, G. B. Gmyrek, J. P. Madej et al., "Serum and peritoneal evaluation of vitamin D-binding protein in women with endometriosis", Postepy Higieny i Medycyny Dos̈wiadczalnej, vol. 62, pp. 103-109, 2008.
100. A. Lasco, A. Catalano, and S. Benvenga, "Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study", Archives of Internal Medicine, vol. 172, no. 4, pp. 366-367, 2012.
101. A. V. Krishnan and D. Feldman, "Mechanisms of the anti-cancer and anti-infammatory actions of vitamin D", Annual Review of Pharmacology and Toxicology, vol. 51, pp. 311-336, 2011.
102. C. S. Spina, L. Ton, M. Yao et al., "Selective vitamin D receptor modulators and their effects on colorectal tumor growth", Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 3-5, pp. 757-762, 2007.
103. C. F. Garland, F. C. Garland, E. D. Gorham et al., "The role of vitamin D in cancer prevention", The American Journal of Public Health, vol. 96, no. 2, pp. 252-261, 2006.
104. P. Chen, P. Hu, D. Xie, Y. Qin, F. Wang, and H. Wang, "Metaanalysis of vitamin D, calcium and the prevention of breast cancer", Breast Cancer Research and Treatment, vol. 121, no. 2, pp. 469-477, 2010.
105. M. Touvier, D. S. M. Chan, R. Lau et al., "Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk", Cancer Epidemiology Biomarkers & Prevention, vol. 20, no. 5, pp. 1003-1016, 2011.
106. M. Pelczynska, J. Wietrzyk, I. Jaroszewicz et al., "Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics", Anticancer Research, vol. 25, no. 3B, pp. 2235-2240, 2005.
107. W. Seubwai, C. Wongkham, A. Puapairoj, N. Khuntikeo, and S. Wongkham, "Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics", Cancer, vol. 109, no. 12, pp. 2497-2505, 2007.
108. M. Chung, J. Lee, T. Terasawa, J. Lau, and T. A. Trikalinos, "Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U. S. preventive services task force", Annals of Internal Medicine, vol. 155, no. 12, pp. 827-838, 2011.
109. S.-L. Liu, Y.-P. Zhao, M.-H. Dai, L. You, Z. Wen, and J.-W. Xu, "Vitamin D status and the risk of pancreatic cancer: a metaanalysis", Chinese Medical Journal, vol. 126, no. 17, pp. 3356-3359, 2013.
110. E. E. Calle, C. Rodriguez, K. Walker-Turmond, and M. J. Tun, "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. Adults", The New England Journal of Medicine, vol. 348, no. 17, pp. 1625-1638, 2003.
111. T. Shanmugalingam, D. Crawley, C. Bosco et al., "Obesity and cancer: the role of vitamin D", BMC Cancer, vol. 14, no. 1, article 712, 2014.
112. A. G. Renehan, J. Frystyk, and A. Flyvbjerg, "Obesity and cancer risk: the role of the insulin-IGF axis", Trends in Endocrinology and Metabolism, vol. 17, no. 8, pp. 328-336, 2006.
113. K. E. Wong, J. Kong, W. Zhang et al., "Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice", The Journal of Biological Chemistry, vol. 286, no. 39, pp. 33804-33810, 2011.
114. S. Y. James, A. G. Mackay, L. Binderup, and K. W. Colston, "Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells", Journal of Endocrinology, vol. 141, no. 3, pp. 555-563, 1994.
115. S. Swami, A. V. Krishnan, and D. Feldman, "1α, 25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells", Clinical Cancer Research, vol. 6, no. 8, pp. 3371-3379, 2000.
116. G. M. Zinser and J. Welsh, "Effect of Vitamin D3 receptor ablation on murine mammary gland development and tumorigenesis", Journal of Steroid Biochemistry and Molecular Biology, vol. 89-90, pp. 433-436, 2004.
117. K. Townsend, K. N. Evans, M. J. Campbell, K. W. Colston, J. S. Adams, and M. Hewison, "Biological actions of extra-renal 25-hydroxyvitamin D-1α-hydroxylase and implications for chemoprevention and treatment", The Journal of Steroid Biochemistry and Molecular Biology, vol. 97, no. 1-2, pp. 103-109, 2005.
118. C. J. Narvaez, D. Matthews, E. LaPorta, K. M. Simmons, S. Beaudin, and J. Welsh, "The impact of vitamin D in breast cancer: genomics, pathways, metabolism", Frontiers in Physiology, vol. 5, article 213, 2014.
119. S. Santagata, A. Takkar, A. Ergonul et al., "Taxonomy of breast cancer based on normal cell phenotype predicts outcome", The Journal of Clinical Investigation, vol. 124, no. 2, pp. 859-870, 2014.
120. K. W. Colston, "Vitamin D and breast cancer risk", Best Practice & Research Clinical Endocrinology & Metabolism, vol. 22, no. 4, pp. 587-599, 2008.
121. M. Almquist, A.-G. Bondeson, L. Bondeson, J. Malm, and J. Banjer, "Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case-control study", International Journal of Cancer, vol. 127, no. 9, pp. 2159-2168, 2010.
122. T. Shao, P. Klein, and M. L. Grossbarda, "Vitamin D and breast cancer", Oncologist, vol. 17, no. 1, pp. 36-45, 2012.
123. S. R. Bauer, S. E. Hankinson, E. R. Bertone-Johnson, and E. L. Ding, "Plasma vitamin d levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies", Medicine, vol. 92, no. 3, pp. 123-131, 2013.
124. E. Amir, R. S. Cecchini, P. A. Ganz et al., "25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1", Breast Cancer Research and Treatment, vol. 133, no. 3, pp. 1077-1088, 2012.
125. D. P. Trivedi, R. Doll, and K. T. Khaw, "Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial", BMJ, vol. 326, no. 7387, pp. 469-472, 2003.
126. J. M. Lappe, D. Travers-Gustafson, K. M. Davies, R. R. Recker, and R. P. Heaney, "Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial", The American Journal of Clinical Nutrition, vol. 85, no. 6, pp. 1586-1591, 2007.
127. M. J. Bolland, A. Grey, G. D. Gamble, and I. R. Reid, "Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set", The American Journal of Clinical Nutrition, vol. 94, no. 4, pp. 1144-1149, 2011.
128. A. Avenell, G. S. MacLennan, D. J. Jenkinson et al., "Long-term follow-up for mortality and cancer in a randomized placebocontrolled trial of vitamin D3 and/or calcium (RECORD Trial)", Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 2, pp. 614-622, 2012.
129. Y. Zheng, J. Zhu, M. Zhou, L. Cui, W. Yao, and Y. Liu, "Metaanalysis of long-term vitamin D supplementation on overall mortality", PLoS ONE, vol. 8, no. 12, Article ID e82109, 2013.
130. A. A. N. Rose, C. Elser, M. Ennis, and P. J. Goodwin, "Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis", Breast Cancer Research and Treatment, vol. 141, no. 3, pp. 331-339, 2013.
131. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, "Global cancer statistics", CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69-90, 2011.
132. M. H. Ahonen, Y. H. Zhuang, R. Aine, T. Ylikomi, and P. Tuohimaa, "Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands", International Journal of Cancer, vol. 86, no. 1, pp. 40-46, 2000.
133. F. Jiang, P. Li, A. J. Fornace Jr., S. V. Nicosia, and W. Bai, "G2/M arrest by 1, 25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer", The Journal of Biological Chemistry, vol. 278, no. 48, pp. 48030-48040, 2003.
134. G. Lurie, L. R. Wilkens, P. J. Thompson et al., "Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk", Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 12, pp. 2566-2571, 2007.
135. E. Y. Adashi, "The climacteric ovary as a functional gonadotropin-driven androgen-producing gland", Fertility and Sterility, vol. 62, no. 1, pp. 20-27, 1994.
136. H. A. Risch, "Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone", Journal of the National Cancer Institute, vol. 90, no. 23, pp. 1774-1786, 1998.
137. C. Villena-Heinsen, R. Meyberg, R. Axt-Fliedner, K. Reitnauer, J. Reichrath, and M. Friedrich, "Immunohistochemical analysis of 1, 25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma", Anticancer Research, vol. 22, no. 4, pp. 2261-2267, 2002.
138. D. M. Parkin, "International variation", Oncogene, vol. 23, no. 38, pp. 6329-6340, 2004.